Actualités 12% Strides Linked TO Apple, Inc. - AVN | Actions American Stock Exchange

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Avanti Comms Group 86m Placing & 194m Debt for 2nd Satellite Launch

Avanti Communications Group Plc 21 December 2009 ? Date: 21 December 2009 On behalf of: Avanti Communications Group plc ("Avanti", "the Group...

American Stock Exchange Lists Merrill Lynch's 12% Callable STRIDES Linked To Apple, Inc.

NEW YORK, Aug. 29 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) opened trading today on Merrill Lynch's 12% Callable STRIDES Linked...

Dr. Gerald Yakatan, Former President and CEO of Avanir Pharmaceuticals, Joins Cobalis Corp. Board of Directors

IRVINE, Calif., Feb. 1 /PRNewswire-FirstCall/ -- Cobalis Corp. (OTC:CLSC) (BULLETIN BOARD: CLSC) , a pharmaceutical development company...

AVANIR Implements One-for-Four Reverse Stock Split and New Stock Ticker Symbol

The previously announced one-for-four reverse split by AVANIR Pharmaceuticals (AMEX:AVN) of its common stock has become effective, with post-split...

AVANIR Licenses Docosanol 10% Cream in Japan

AVANIR Pharmaceuticals (AMEX:AVN) announced today that it has signed an exclusive agreement with a leading importer and distributor of...

AVANIR Pharmaceuticals Hires Randall E. Kaye, M.D. as Vice President of Medical Affairs

AVANIR Pharmaceuticals (AMEX:AVN) announced today that Randall E. Kaye, M.D. has joined the company in the newly created role of Vice President of...

AVANIR's Board of Directors Approves the Implementation of a One-for-Four Reverse Stock Split

AVANIR Pharmaceuticals (AMEX: AVN) announced today that its Board of Directors has approved the implementation of a one-for-four reverse split of...

AVANIR Pharmaceuticals Invites Investors to the 24th Annual JPMorgan Healthcare Conference Webcast

AVANIR Pharmaceuticals (AMEX:AVN) will be presenting at the 24th Annual JPMorgan Healthcare Conference on Wednesday, January 11, 2005, at 4:00...

Phase I Reverse Cholesterol Transport Trial Initiated; AVANIR to Receive $5 Million Milestone

AVANIR Pharmaceuticals (AMEX:AVN) announced today that a Phase I study has been initiated in partnership with AstraZeneca UK Limited (AstraZeneca...

AVANIR Pharmaceuticals Invites Investors to the Lazard Capital Markets Life Sciences Conference Webcast

AVANIR Pharmaceuticals (AMEX: AVN) announced today that its presentation at the Lazard Capital Markets Annual Life Sciences Conference in New...

AVANIR Pharmaceuticals Appoints Scott M. Whitcup, M.D., to Board of Directors

AVANIR Pharmaceuticals (AMEX:AVN) announced today that Scott M. Whitcup, M.D., has been elected to the company's board of directors to fill a...

AVANIR Pharmaceuticals Invites Investors to the CIBC and the Rodman & Renshaw Healthcare Conference Webcasts

AVANIR Pharmaceuticals (AMEX: AVN) will be presenting at CIBC World Markets 16th Annual Healthcare Conference on Tuesday, November 8, 2005, at...

AVANIR Announces $16 Million Common Stock Offering

AVANIR Pharmaceuticals (AMEX: AVN) today announced it has obtained commitments to purchase $16.15 million of its common stock in a...

AVANIR Pharmaceuticals Appoints Craig Wheeler to Board Of Directors

AVANIR Pharmaceuticals (AMEX:AVN) announced today that Craig A. Wheeler has been elected to the company's Board of Directors to fill a vacancy...

Further Update on AVANIR's Neurodex(TM) New Drug Application

AVANIR Pharmaceuticals (AMEX:AVN) announced that during discussion with the U.S. Food and Drug Administration (FDA) yesterday regarding AVANIR's...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

12% Strides Linked TO Apple, Inc. (AVN)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

AVN Actualités

Avanti Comms Group 86m Placing & 194m Debt for 2nd Satellite Launch

American Stock Exchange Lists Merrill Lynch's 12% Callable STRIDES Linked To Apple, Inc.

Dr. Gerald Yakatan, Former President and CEO of Avanir Pharmaceuticals, Joins Cobalis Corp. Board of Directors

AVANIR Implements One-for-Four Reverse Stock Split and New Stock Ticker Symbol

AVANIR Licenses Docosanol 10% Cream in Japan

AVANIR Pharmaceuticals Hires Randall E. Kaye, M.D. as Vice President of Medical Affairs

AVANIR's Board of Directors Approves the Implementation of a One-for-Four Reverse Stock Split

AVANIR Pharmaceuticals Invites Investors to the 24th Annual JPMorgan Healthcare Conference Webcast

Phase I Reverse Cholesterol Transport Trial Initiated; AVANIR to Receive $5 Million Milestone

AVANIR Pharmaceuticals Invites Investors to the Lazard Capital Markets Life Sciences Conference Webcast

AVANIR Pharmaceuticals Appoints Scott M. Whitcup, M.D., to Board of Directors

AVANIR Pharmaceuticals Invites Investors to the CIBC and the Rodman & Renshaw Healthcare Conference Webcasts

AVANIR Announces $16 Million Common Stock Offering

AVANIR Pharmaceuticals Appoints Craig Wheeler to Board Of Directors

Further Update on AVANIR's Neurodex(TM) New Drug Application

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

12% Strides Linked TO Apple, Inc. (AVN) Actualités

12% Strides Linked TO Apple, Inc. (AVN)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

AVN Actualités

Avanti Comms Group 86m Placing & 194m Debt for 2nd Satellite Launch

American Stock Exchange Lists Merrill Lynch's 12% Callable STRIDES Linked To Apple, Inc.

Dr. Gerald Yakatan, Former President and CEO of Avanir Pharmaceuticals, Joins Cobalis Corp. Board of Directors

AVANIR Implements One-for-Four Reverse Stock Split and New Stock Ticker Symbol

AVANIR Licenses Docosanol 10% Cream in Japan

AVANIR Pharmaceuticals Hires Randall E. Kaye, M.D. as Vice President of Medical Affairs

AVANIR's Board of Directors Approves the Implementation of a One-for-Four Reverse Stock Split

AVANIR Pharmaceuticals Invites Investors to the 24th Annual JPMorgan Healthcare Conference Webcast

Phase I Reverse Cholesterol Transport Trial Initiated; AVANIR to Receive $5 Million Milestone

AVANIR Pharmaceuticals Invites Investors to the Lazard Capital Markets Life Sciences Conference Webcast

AVANIR Pharmaceuticals Appoints Scott M. Whitcup, M.D., to Board of Directors

AVANIR Pharmaceuticals Invites Investors to the CIBC and the Rodman & Renshaw Healthcare Conference Webcasts

AVANIR Announces $16 Million Common Stock Offering

AVANIR Pharmaceuticals Appoints Craig Wheeler to Board Of Directors

Further Update on AVANIR's Neurodex(TM) New Drug Application

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités